Document Detail

Transthoracic endoscopic T-2, 3 sympathectomy for facial hyperhidrosis.
MedLine Citation:
PMID:  11695712     Owner:  NLM     Status:  MEDLINE    
Twenty-five patients (20 men and 5 women) with the chief complaint of facial hyperhidrosis were treated by transthoracic endoscopic T-2, 3 sympathectomy. All patients were essentially in good health except the embarrassment of facial sweating. Fifteen of them also suffered from distressing palmar hyperhidrosis. The ages ranged from 18 to 40 years (mean age 25 years). All of them except two obtained a satisfactory improvement of facial hyperhidrosis after 3 months to 2 years of follow-up. One man demonstrated very mild ptosis in the right eye. Pre- and postoperative sympathetic skin response (SSR) revealed the absence rate from 20% to 72% with electrical stimulation (p < 0.05). This study shows that T-2, 3 sympathectomy is a choice of treatment for facial hyperhidrosis and sympathetic supply to the face may at least partly be from T-2, 3 level.
H J Chen; K Lu; C L Liang
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Autonomic neuroscience : basic & clinical     Volume:  93     ISSN:  1566-0702     ISO Abbreviation:  Auton Neurosci     Publication Date:  2001 Oct 
Date Detail:
Created Date:  2001-11-06     Completed Date:  2002-03-26     Revised Date:  2009-08-12    
Medline Journal Info:
Nlm Unique ID:  100909359     Medline TA:  Auton Neurosci     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  91-4     Citation Subset:  IM    
Department of Neurosurgery, Chang Gung University and Memorial Hospital at Kaohsiung, Kaohsiung Hsien, Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Face / innervation*
Follow-Up Studies
Galvanic Skin Response
Hyperhidrosis / surgery*
Sympathectomy / methods*
Thoracic Vertebrae
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Heterogeneous distribution of a gap junction protein, connexin43, in the gastroduodenal junction of ...
Next Document:  Pharmacokinetics and bioavailability of sustained release and conventional formulation of acyclovir.